MetLife stock heads into the open after a flat 0.1% gain
Published on 09/18/2026 at 06:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
MetLife stock closed at USD 97.35 on the New York Stock Exchange on September 17, 2026, edging 0.1% higher versus the prior session with U.S. markets already shut for the day and trading in USD terms. Compared with its 52-week range between USD 67.33 and USD 100.93, the share price remained in the upper half of its yearly band at that close, while the S&P 500 finished the same session at 7,637.76, up 1.14%.
September 17, 2026 in numbers
MetLife Inc. (ISIN US59156R1086, NYSE: MET) saw its shares move from an open of USD 97.94 to a close of USD 97.35 on September 17, 2026, with an intraday high of USD 98.32 and a low of USD 96.80 as trading volume reached 2,760,405 shares according to Nasdaq data compiled on Yahoo Finance. The previous session’s close stood at USD 97.23, implying a 0.12% gain on the day and leaving the insurer’s intraday market capitalization around USD 61.86 billion in NYSE trading. For context, the S&P 500 advanced 1.14% to 7,637.76, while the Nasdaq Composite climbed 1.69% to 26,418.30 in the same session, indicating that MetLife lagged the broader equity benchmarks despite its modest uptick.
Recent performance figures underline that the September 17, 2026 close came after a solid run over the year to date. Trailing total return data as of September 17, 2026 show that MetLife delivered a 25.93% year-to-date gain versus 11.57% for the S&P 500, and a 27.26% one-year return compared with 15.72% for the index, highlighting that the stock has outperformed the benchmark over both horizons. As a recap of the prior week’s trading, an analysis on ad hoc news noted that MetLife stock closed at USD 98.21 on September 15, 2026, up 0.47% on the day, with the share price supported by a recent earnings beat and capital return announcements in the preceding quarter.
Today’s focus for MetLife
Today, September 18, 2026, investors continue to frame MetLife’s share price against its Q2 2026 fundamentals and capital return plans. As summarized by ad hoc news, the insurer reported Q2 2026 earnings of USD 2.43 per share versus consensus expectations of USD 2.30, alongside reported quarterly revenue of around USD 19.07 billion, delivering a clear earnings beat that has underpinned sentiment in recent sessions. The same report highlights a regular dividend around USD 2.37 per share annually and notes that MetLife’s board has authorized a USD 3.0 billion share buyback program in 2026, adding a further layer of support for the stock through potential share repurchases.
Looking ahead, the next scheduled earnings date for MetLife is November 9, 2026, per the earnings calendar embedded in the Nasdaq-based overview on Yahoo Finance, meaning that today’s trading will occur in the run-up phase to the company’s subsequent quarterly update rather than around a fresh report. Broader market factors also remain relevant, with U.S. indices having rebounded on September 17, 2026 as bond yields slipped and oil prices retreated, a backdrop that can influence financials such as life insurers through rate expectations and equity market risk appetite, as reflected in the same market wrap on Yahoo Finance covering the move in the S&P 500 and Nasdaq.
